title: [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
abstract: The authors studied 67 patients with ischemic heart disease associated with hypertensive disease and revealed that the use of beta-adrenoblockaders and calcium antagonists resulted in a reduction of the manifestations of the disease, increase of physical load tolerance, optimization of its hemodynamic and oxygen provision. In patients under 60 years of age of beta-adrenoblockaders resulted in an increase of the myocardial contractility. This was not observed in those over 60 years of age. It is concluded that in patients combining IHD with hypertensive disease under 60 it is more preferable to use beta-adrenoblockers, in those over 60--calcium antagonists.
authors.forename: E V
authors.initials: EV
authors.lastname: Andrushchenko
authors.forename: V P
authors.initials: VP
authors.lastname: Chmir
authors.forename: E A
authors.initials: EA
authors.lastname: Krasovskaia
authors.forename: T A
authors.initials: TA
authors.lastname: Malanchuk
authors.forename: I I
authors.initials: II
authors.lastname: Polishchuk
authors.forename: O B
authors.initials: OB
authors.lastname: Iashchenko
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000375:Aging / Q000187:drug effects / Q000502:physiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D005080:Exercise Test; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D011433:Propranolol; D014700:Verapamil